Cargando…
EphrinA1-Fc Attenuates Ventricular Remodeling and Dysfunction in Chronically Nonreperfused WT but not EphA2-R-M mice
Background: EphrinA1-Fc abolishes acute I/R injury and attenuates nonreperfused cardiac injury 4 days after permanent occlusion in mice. The goal of this study was to assess the capacity of a single intramyocardial administration of ephrinA1-Fc at the time of coronary artery ligation, to determine t...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7461052/ https://www.ncbi.nlm.nih.gov/pubmed/32823610 http://dx.doi.org/10.3390/ijms21165811 |
_version_ | 1783576710896156672 |
---|---|
author | Whitehurst, K’Shylah S. Chan, Victoria A. Estes, Heather K. Valsaraj, Smrithi Kent, Susan Sharma, Uma M. Chase, R. Christopher Bhuiyan, Maliha Virag, Jitka A. I. |
author_facet | Whitehurst, K’Shylah S. Chan, Victoria A. Estes, Heather K. Valsaraj, Smrithi Kent, Susan Sharma, Uma M. Chase, R. Christopher Bhuiyan, Maliha Virag, Jitka A. I. |
author_sort | Whitehurst, K’Shylah S. |
collection | PubMed |
description | Background: EphrinA1-Fc abolishes acute I/R injury and attenuates nonreperfused cardiac injury 4 days after permanent occlusion in mice. The goal of this study was to assess the capacity of a single intramyocardial administration of ephrinA1-Fc at the time of coronary artery ligation, to determine the degree to which early salvage effects translate to reduced adverse remodeling after 4 weeks of nonreperfused myocardial infarction (MI) in wild-type B6 and EphA2-R-M (EphA2 receptor null) mice. Methods: At 4 weeks post-MI, echocardiography, histologic and immunohistochemical analyses of B6 mouse hearts were performed. Primary mouse cardiac fibroblasts (FBs) isolated from B6 mice cultured in the presence of low and high dose ephrinA1-Fc, both with and without pro-fibrotic TGF-β stimulation and Western blots, were probed for relative expression of remodeling proteins MMP-2, MMP-9 and TIMP-1, in addition to DDR2 and (p)SMAD2/3/totalSMAD2/3. Results: EphrinA1-Fc preserved a significant degree of contractile function, decreased adverse left ventricular remodeling, attenuated excessive compensatory hypertrophy, and decreased interstitial fibrosis in wild-type (WT) B6 mouse hearts. In contrast, most of these parameters were poorer in ephrinA1-Fc-treated EphA2-R-M mice. Of note, fibrosis was proportionately decreased, implying that other EphA receptor(s) are more important in regulating the pro-fibrotic response. Primary FBs showed disparate alteration of MMP-2, MMP-9 and TIMP-1, as well as DDR2 and p-SMAD2/3/totalSMAD2/3, which indicates that matrix remodeling and cardiac fibrosis in the injured heart are influenced by ephrinA1-Fc. Conclusion: This study demonstrates the capacity of a single administration of ephrinA1-Fc at the onset of injury to attenuate long-term nonreperfused post-MI ventricular remodeling that results in progressive heart failure, and the important role of EphA2 in mitigating the deleterious effects. |
format | Online Article Text |
id | pubmed-7461052 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-74610522020-09-14 EphrinA1-Fc Attenuates Ventricular Remodeling and Dysfunction in Chronically Nonreperfused WT but not EphA2-R-M mice Whitehurst, K’Shylah S. Chan, Victoria A. Estes, Heather K. Valsaraj, Smrithi Kent, Susan Sharma, Uma M. Chase, R. Christopher Bhuiyan, Maliha Virag, Jitka A. I. Int J Mol Sci Article Background: EphrinA1-Fc abolishes acute I/R injury and attenuates nonreperfused cardiac injury 4 days after permanent occlusion in mice. The goal of this study was to assess the capacity of a single intramyocardial administration of ephrinA1-Fc at the time of coronary artery ligation, to determine the degree to which early salvage effects translate to reduced adverse remodeling after 4 weeks of nonreperfused myocardial infarction (MI) in wild-type B6 and EphA2-R-M (EphA2 receptor null) mice. Methods: At 4 weeks post-MI, echocardiography, histologic and immunohistochemical analyses of B6 mouse hearts were performed. Primary mouse cardiac fibroblasts (FBs) isolated from B6 mice cultured in the presence of low and high dose ephrinA1-Fc, both with and without pro-fibrotic TGF-β stimulation and Western blots, were probed for relative expression of remodeling proteins MMP-2, MMP-9 and TIMP-1, in addition to DDR2 and (p)SMAD2/3/totalSMAD2/3. Results: EphrinA1-Fc preserved a significant degree of contractile function, decreased adverse left ventricular remodeling, attenuated excessive compensatory hypertrophy, and decreased interstitial fibrosis in wild-type (WT) B6 mouse hearts. In contrast, most of these parameters were poorer in ephrinA1-Fc-treated EphA2-R-M mice. Of note, fibrosis was proportionately decreased, implying that other EphA receptor(s) are more important in regulating the pro-fibrotic response. Primary FBs showed disparate alteration of MMP-2, MMP-9 and TIMP-1, as well as DDR2 and p-SMAD2/3/totalSMAD2/3, which indicates that matrix remodeling and cardiac fibrosis in the injured heart are influenced by ephrinA1-Fc. Conclusion: This study demonstrates the capacity of a single administration of ephrinA1-Fc at the onset of injury to attenuate long-term nonreperfused post-MI ventricular remodeling that results in progressive heart failure, and the important role of EphA2 in mitigating the deleterious effects. MDPI 2020-08-13 /pmc/articles/PMC7461052/ /pubmed/32823610 http://dx.doi.org/10.3390/ijms21165811 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Whitehurst, K’Shylah S. Chan, Victoria A. Estes, Heather K. Valsaraj, Smrithi Kent, Susan Sharma, Uma M. Chase, R. Christopher Bhuiyan, Maliha Virag, Jitka A. I. EphrinA1-Fc Attenuates Ventricular Remodeling and Dysfunction in Chronically Nonreperfused WT but not EphA2-R-M mice |
title | EphrinA1-Fc Attenuates Ventricular Remodeling and Dysfunction in Chronically Nonreperfused WT but not EphA2-R-M mice |
title_full | EphrinA1-Fc Attenuates Ventricular Remodeling and Dysfunction in Chronically Nonreperfused WT but not EphA2-R-M mice |
title_fullStr | EphrinA1-Fc Attenuates Ventricular Remodeling and Dysfunction in Chronically Nonreperfused WT but not EphA2-R-M mice |
title_full_unstemmed | EphrinA1-Fc Attenuates Ventricular Remodeling and Dysfunction in Chronically Nonreperfused WT but not EphA2-R-M mice |
title_short | EphrinA1-Fc Attenuates Ventricular Remodeling and Dysfunction in Chronically Nonreperfused WT but not EphA2-R-M mice |
title_sort | ephrina1-fc attenuates ventricular remodeling and dysfunction in chronically nonreperfused wt but not epha2-r-m mice |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7461052/ https://www.ncbi.nlm.nih.gov/pubmed/32823610 http://dx.doi.org/10.3390/ijms21165811 |
work_keys_str_mv | AT whitehurstkshylahs ephrina1fcattenuatesventricularremodelinganddysfunctioninchronicallynonreperfusedwtbutnotepha2rmmice AT chanvictoriaa ephrina1fcattenuatesventricularremodelinganddysfunctioninchronicallynonreperfusedwtbutnotepha2rmmice AT estesheatherk ephrina1fcattenuatesventricularremodelinganddysfunctioninchronicallynonreperfusedwtbutnotepha2rmmice AT valsarajsmrithi ephrina1fcattenuatesventricularremodelinganddysfunctioninchronicallynonreperfusedwtbutnotepha2rmmice AT kentsusan ephrina1fcattenuatesventricularremodelinganddysfunctioninchronicallynonreperfusedwtbutnotepha2rmmice AT sharmaumam ephrina1fcattenuatesventricularremodelinganddysfunctioninchronicallynonreperfusedwtbutnotepha2rmmice AT chaserchristopher ephrina1fcattenuatesventricularremodelinganddysfunctioninchronicallynonreperfusedwtbutnotepha2rmmice AT bhuiyanmaliha ephrina1fcattenuatesventricularremodelinganddysfunctioninchronicallynonreperfusedwtbutnotepha2rmmice AT viragjitkaai ephrina1fcattenuatesventricularremodelinganddysfunctioninchronicallynonreperfusedwtbutnotepha2rmmice |